1-2 of 2
Junjie Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

QHRD107 (CDK9 Inhibitor), venetoclax, and azacitidine combination therapy (107VA regimen) in relapsed/refractory Acute Myeloid Leukemia: Data updates and subgroup analysis

Free
Yunxiang Zhang, Min Wu, Wen Wu, Zheng Ge, Ligen Liu, Chunyan Ji, Weiying Gu, Chunling Wang, Yanli Zhang, Wei Yang, Fuling Zhou, Zhengping Yu, Min Ji, Banghe Ding, Shudong Wang, Xiang Zhou, Lijun Wei, Hengwen Song, Yan Zhou, Bomin Yin, Zhichao Shao, Mengdan Sun, Qi Jiang, Junjie Lu, Junmin Li
Journal: Blood
Blood (2025) 146 (Supplement 1): 5205.
https://doi.org/10.1182/blood-2025-5205
Published: 2025
Journal Articles

High Remission Rates in Relapsed/Refractory Acute Myeloid Leukemia with QHRD107 (CDK9 Inhibitor), Venetoclax, and Azacitidine Combination Therapy (107VA regimen) : Preliminary Results of a Phase 2a Study

Free
Min Wu, Yunxiang Zhang, Wen Wu, Zheng Ge, Ligen Liu, Chunyan Ji, Weiying Gu, Chunling Wang, Yanli Zhang, Wei Yang, Fuling Zhou, Zhengping Yu, Min Ji, Banghe Ding, Shudong Wang, Lijun Wei, Hengwen Song, Yan Zhou, Bomin Yin, Zhichao Shao, Mengdan Sun, Qi Jiang, Junjie Lu, Junmin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 2882.
https://doi.org/10.1182/blood-2024-199412
Published: 2024